Association of Vascular Access Type with Inflammatory Marker Levels in Maintenance Hemodialysis Patients

Authors

  • Ramanath Dukkipati,

    1. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance and Los Angeles, California
    2. David Geffen School of Medicine at UCLA, Torrance and Los Angeles, California
    3. Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, California
    Search for more papers by this author
    • These authors contributed equally to this research and preparation of this manuscript.
  • Miklos Z Molnar,

    1. Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, California
    2. Division of Nephrology, Memphis Veterans Affairs Medical Center, Memphis, Tennessee
    Search for more papers by this author
    • These authors contributed equally to this research and preparation of this manuscript.
  • Jongha Park,

    1. Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, California
    Search for more papers by this author
  • Jennie Jing,

    1. Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, California
    Search for more papers by this author
  • Csaba P. Kovesdy,

    1. University of Tennessee Health Science Center, Memphis, Tennessee
    2. Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada
    Search for more papers by this author
  • Raahil Kajani,

    1. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance and Los Angeles, California
    Search for more papers by this author
  • Kamyar Kalantar-Zadeh

    1. Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, California
    Search for more papers by this author

Address Correspondence to: Ramanath Dukkipati, MD., Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, 1124 West Carson Street, C-1 Annex, Torrance, CA 90509, or e-mail: ramdukkipati@gmail.com.

Abstract

Aggressive NIH is a common histopathological lesion found at the sites of venous stenosis in arteriovenous fistula (AVF) and arteriovenous grafts (AVG). Inflammatory mediators have been proposed to play a pathogenic role in NIH, but there is paucity of data evaluating this hypothesis in clinical studies or in animal models. Serum levels of inflammatory mediators can potentially identify patients at high risk of AVF and AVG dysfunction. In a cross-sectional cohort study of 754 HD patients who were part of the NIED study cohort, we examined the associations between inflammatory markers including serum interleukin (IL) 1β, IL-6, C-reactive protein (CRP), and tumor necrosis factor-α (TNF-α) and type of vascular access. Unadjusted and multivariate-adjusted linear regression models were used. In addition, time-dependent regression model was used to assess the association between inflammatory markers and mortality. We observed that in the multivariate-adjusted model, inflammatory mediators interleukin-6 (IL-6), interleukin–1L-ß (IL-1ß), and C-reactive protein (CRP), the predicted value in hemodialysis patients, are lowest in patients with AVF and highest in central venous catheter (CVC) and AVG even in case-mix and malnutrition–inflammation complex syndrome (MICS)-adjusted models. IL-6 and CRP levels fall consistently in the same patients when AVG or CVC is changed to AVF and increase if the same patient changes access from AVF to AVG or CVC. Obesity is a risk factor for fistula failure and fistulas are associated with the lowest mortality compared with CVC and AVG. We did not find any statistically significant association between tumor necrosis factor–α (TNF- α) and vascular access outcomes. Higher levels of inflammatory mediators seen in CVC and AVG compared with AVF could potentially explain the higher mortality seen in patients with CVC and AVG compared with AVF.

Ancillary